All Stories

  1. Real-World Experience with Ruxolitinib in Myeloproliferative Neoplasms: A Single-Center Study from Oman
  2. Clinical and laboratory manifestations and outcomes of human parvovirus B19 infections in sickle cell anemia with emphasis on the impact of hydroxyurea
  3. Rapid withdrawal of voxelotor can precipitate sickle cell disease related crisis
  4. A Systematic Review of Large Language Models in Medical Specialties: Applications, Challenges and Future Directions
  5. Immune reconstitution and survival, following hematopoietic stem cell transplantation in Omani patients with inborn errors of immunity
  6. Current Status and Management of Chronic Myeloid Leukemia in the Gulf Region: Survey Results and Expert Opinion
  7. The role of preoperative transfusion in sickle cell disease, a systematic review and meta-analysis
  8. CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA
  9. Multi-center study on mortality in children, and adults with sickle cell anemia-risk factors and causes of death
  10. Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry
  11. Appropriate Antiviral Therapy Can Prevent Hepatitis B Reactivation & Progression in Chronic Myeloid Leukemia on Therapy with Tyrosine Kinase Inhibitors
  12. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently
  13. Differential Production of Midkine and Pleiotrophin by Innate APCs upon Stimulation through Nucleic Acid-Sensing TLRs
  14. Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East
  15. Artificial intelligence in sickle disease
  16. Influence of Voxelotor–hemoglobin complexes in the estimation of hemoglobin S levels by the current standard of care laboratory evaluation techniques
  17. The Role of Preoperative Transfusion in Sickle Cell Disease, a Systematic Review and Meta-Analysis
  18. ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS.
  19. Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells
  20. Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
  21. Clinicopathological Profile of Paroxysmal Nocturnal Hemoglobinuria among Omani Patients: A Case Series
  22. The Challenges in Diagnosis and Management of Acquired Thrombotic Thrombocytopenic Purpura: Consensus Report from Three Gulf Countries
  23. Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production
  24. Transplant Associated Graft versus Host Disease
  25. Predicting risk factors for thromboembolic complications in patients with sickle cell anaemia – lessons learned for prophylaxis
  26. A reanalysis of pain crises data from the pivotal l-glutamine in sickle cell disease trial
  27. Iron Overload in Patients With Heavily Transfused Sickle Cell Disease—Correlation of Serum Ferritin With Cardiac T2* MRI (CMRTools), Liver T2* MRI, and R2-MRI (Ferriscan®)
  28. Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease
  29. Nutritional and Hematological Status of Sudanese Women of Childbearing Age with Steady-state Sickle Cell Anemia
  30. Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia
  31. Clinical and laboratory features of Hemoglobin La Desirade variant in association with sickle cell and alpha thalassemia genes
  32. Respiratory Viral Infections in Sickle Cell Anemia: Special Emphasis on H1N1 Co-infection
  33. Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study
  34. A A Multicentre ICET-A Study of Confirmed SARS-CoV-2 Infection in Patients with Hemoglobinopathies: Preliminary Data from 10 Countries
  35. Efficiency of day 4 compared to day 6 stem cell mobilization in allogeneic stem cell donors
  36. Hematopoietic stem cell transplantation for patients with sickle cell disease in the Eastern Mediterranean
  37. Unique aspects of Graft-versus-host-disease management in the Eastern Mediterranean region: Report from the Eastern Mediterranean blood and marrow transplantation group: Special report
  38. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations
  39. Predictors of impending acute chest syndrome in patients with sickle cell anaemia
  40. Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients
  41. Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations
  42. PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
  43. Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group
  44. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
  45. THE USE OF HPLC AS A TOOL FOR NEONATAL CORD BLOOD SCREENING OF HAEMOGLOBINOPATHY - A VALIDATION STUDY
  46. Can Gestational Anemia be Alleviated with Increased Awareness of its Causes and Management Strategies? Implications for Health Care Services
  47. Stability of fetal hemoglobin levels in patients receiving metformin therapy
  48. A novel p.Pro353His SERPINC1 mutation in the thrombin-binding region affecting stability of Antithrombin molecule in an extended Omani family
  49. First Cytogenetic Profile of Omani Patients with de novo Myelodysplastic Syndromes: Comparison with data from Asia, Africa, Europe and North and South America
  50. Impact of Educational Activities in Reducing Pre-Analytical Laboratory Errors: A quality initiative
  51. Haemoglobin Fontainebleau (HBA2: c. 64G>C) in Oman: molecular and haematological characteristics and interaction with various haemoglobinopathies
  52. Therapeutic drug monitoring-guided dosing of busulfan differs from weight-based dosing in hematopoietic stem cell transplant patients
  53. INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.
  54. Regulatory B Cells Are Functionally Impaired in Patients Having Hemophilia A With Inhibitors
  55. Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic Leukemia
  56. ALLOIMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE AND THALASSAEMIA: EXPERIENCE OF SINGLE CENTRE FROM OMAN
  57. Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures
  58. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group
  59. First Implementation of Transfusion Consent Policy in Oman: Audit of compliance from a tertiary care university hospital
  60. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011–2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT)
  61. Accuracy of Platelet Counting by Optical and Impedance Methods in Patients with Thrombocytopaenia and Microcytosis
  62. Mode of delivery and risk of intracranial haemorrhage in newborns with severe haemophilia A: a multicentre study in Gulf region
  63. Duplication 1q as primary and 3q in t(3;13) as secondary aberration in Fanconi anemia: Implications and literature review
  64. SERUM TOTAL BILIRUBIN, NOT CHOLELITHIASIS, IS INFLUENCED BY UGT1A1 POLYMORPHISM, ALPHA THALASSEMIA AND S GENOTYPE: FIRST REPORT ON COMPARISON BETWEEN ARAB-INDIAN AND AFRICAN S GENES
  65. Aetiological profile of women presenting with premature ovarian failure to a single tertiary care center in Oman
  66. Biclonal Gammopathy in Chronic Lymphocytic Leukemia: Case Report and Review of the Literature
  67. Rituximab Leads to Long Remissions in Patients with Chronic Immune Thrombocytopenia
  68. Safety of stem cell mobilization in donors with sickle cell trait
  69. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies
  70. The pneumatic tube system does not affect complete blood count results; a validation study at a tertiary care hospital
  71. Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman
  72. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature
  73. A stepwise α-thalassemia screening strategy in high-prevalence areas
  74. Genital Ulcer Development in Patients with Acute Promyelocytic Leukaemia Treated with All-Trans Retinoic Acid: A Case Series
  75. Transcranial Doppler Ultrasonography in Sickle Cell Disease
  76. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus
  77. Idiopathic thrombocytopenic purpura and hypokalaemic dRTA with compensated haemolysis and striking acanthocytosis in a band 3 (SLC4A1/AE1) A858D homozygote
  78. Coexistence of sickle cell disease and severe congenital neutropenia: first impressions can be deceiving
  79. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients
  80. Complications of PORT-A-CATH® in patients with sickle cell disease
  81. dRTA and hemolytic anemia: first detailed description of SLC4A1 A858D mutation in homozygous state
  82. The β-globin promoter −71 C>T mutation is a β+ thalassemic allele
  83. Trends of Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region, 1984-2007
  84. Acute massive splenic infarction with complete liquefaction of the spleen in sickle cell disease
  85. Severity ranking of non-deletional alpha thalassemic alleles: insights from an Omani family study
  86. Sub-optimal serum gentamicin concentrations in sickle cell disease patients utilizing the Hartford protocol
  87. Complete recovery following sudden sensorineural hearing loss in a patient with sickle cell disease
  88. Hb Sheffield [β58(E2)Pro→His] in Oman: Potential Pitfall in Genetic Counseling
  89. Sensorineural hearing loss in sickle cell disease-A prospective study from Oman
  90. Clinical and laboratory characteristics of patients with sickle-cell and autoimmune/connective tissue diseases
  91. Predictive Value of Neutrophil to Lymphocyte Ratio in Outcomes of Patients with Acute Coronary Syndrome
  92. Coexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab
  93. Review: Management of Painful Vaso-Occlusive Crisis of Sickle-Cell Anemia: Consensus Opinion
  94. Forecasting Hemoglobinopathy Burden Through Neonatal Screening in Omani Neonates
  95. Isochromosome 9q as a sole anomaly in an Omani boy with acute lymphoblastic leukaemia
  96. Splenectomy for haematological disorders: A single center study in 150 patients from Oman
  97. Orbital Infarction in Sickle Cell Disease
  98. Hematopoietic stem cell transplantation in Oman
  99. Arterial and Venous Thrombotic Complications with Thalidomide in Multiple Myeloma
  100. Complex t(8;13;21)(q22;q14;q22)–A Novel Variant of t(8;21) in a Patient with Acute Myeloid Leukemia (AML–M2)
  101. Familial lymphoma in an Omani kindred with identical class II HLA type
  102. Biphenotypic leukemia with interstitial del(9)(q22q32) as a sole abnormality
  103. Trisomy 21 as a Sole Acquired Abnormality in an Adult Omani Patient with CD7- and CD9-Positive Acute Myeloid Leukemia
  104. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia
  105. Sickle cell?haemoglobin E (HbSE) compound heterozygosity: a clinical and haematological study
  106. Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma
  107. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease
  108. Recovery of normal autologous myelopoiesis after graft rejection following allogeneic bone marrow transplant for agnogenic myeloid metaplasia
  109. Hereditary thrombophilia in ethnic omani patients
  110. Successful outcome with anagrelide in pregnancy
  111. Imatinib in pregnancy
  112. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis
  113. Cytokine profile of sickle cell disease in Oman
  114. Cytokines in Sickle Cell Disease
  115. Erythroid hypoplasia associated with leptospirosis
  116. Orbital involvement in sickle cell disease: A report of five cases and review literature